Home›Companies›Biotech & Pharma›Bright Uro

Bright Uro, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 5, 2025·Suggest an edit

About Bright Uro

Bright Uro is a private company based in Irvine, California, incorporated in 2021 in Delaware. It has reported $46,024,759 raised in two offerings on Form D since December 2023. Its chief executive is Derek Herrera.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 20, 2025Jul 3, 2025amended Sep 5, 2025$14,999,999fully sold35$428KEquityRule 506(b)Form D/A ↗1 earlier filing
Nov 14, 2023Dec 5, 2023amended Jul 3, 2025$31,024,760of $32.0M target108$287KEquityRule 506(b)Form D/A ↗3 earlier filings
Total, two offerings$46,024,759

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bright Uro's Form D filed Sep 5, 2025.

KH
Kevin Hershberger
Executive officer
DH
Derek Herrera
Chief Executive Officer and director
KA
Kurt Azarbarzin
Director
Also CEO and director at Precision IO Group.

Earlier filings also listed Kevin Herschberger (executive officer, last listed Jul 2025).

Sources

  1. SECBright Uro, Inc. Form D, filed Jul 3, 2025
  2. SECBright Uro, Inc. Form D/A, filed Sep 23, 2024
  3. SECBright Uro, Inc. Form D/A, filed May 10, 2024
  4. SECBright Uro, Inc. Form D, filed Dec 5, 2023
  5. SECBright Uro, Inc. filing history